What’s Next For TG Therapeutics Inc. Stock After $15?
March 16, 2017 at 07:04 AM EDT
TGTX is a great M&A candidate. TG-1101 is used with ibrutinib. That makes TG Therapeutics a top of the line target for both Johnson & Johnson and AbbVie.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.